相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A
M. C. Ozelo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Phosphatidylserine Lipid Nanoparticles Promote Systemic RNA Delivery to Secondary Lymphoid Organs
Sijin Luozhong et al.
NANO LETTERS (2022)
The clinical landscape for AAV gene therapies
Dmitry A. Kuzmin et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
T Cell-Mediated Immune Responses to AAV and AAV Vectors
Hildegund C. J. Ertl
FRONTIERS IN IMMUNOLOGY (2021)
AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
Helena Costa Verdera et al.
MOLECULAR THERAPY (2020)
De novo design of functional zwitterionic biomimetic material for immunomodulation
Bowen Li et al.
SCIENCE ADVANCES (2020)
Zwitterionic Peptide Cloak Mimics Protein Surfaces for Protein Protection
Zhefan Yuan et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
Rapamycin-PLGA microparticles prevent senescence, sustain cartilage matrix production under stress and exhibit prolonged retention in mouse joints
Kaamini M. Dhanabalan et al.
BIOMATERIALS SCIENCE (2020)
Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN
Christian Hinderer et al.
HUMAN GENE THERAPY (2018)
Gene Therapy with BMN 270 Results in Therapeutic Levels of FVIII in Mice and Primates and Normalization of Bleeding in Hemophilic Mice
Stuart Bunting et al.
MOLECULAR THERAPY (2018)
The Effect of Immunosuppressive Drugs on MDSCs in Transplantation
Fan Yang et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Emerging Issues in AAV-Mediated In Vivo Gene Therapy
Pasqualina Colella et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Dosage Thresholds and Influence of Transgene Cassette in Adeno-Associated Virus-Related Toxicity
Hanen Khabou et al.
HUMAN GENE THERAPY (2018)
The genetic basis of disease
Maria Jackson et al.
UNDERSTANDING BIOCHEMISTRY 4 (2018)
Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
Amine Meliani et al.
NATURE COMMUNICATIONS (2018)
Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems
Ken Y. Chan et al.
NATURE NEUROSCIENCE (2017)
Combination therapy for inhibitor reversal in haemophilia A using monoclonal anti-CD20 and rapamycin
Moanaro Biswas et al.
THROMBOSIS AND HAEMOSTASIS (2017)
Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer
R. B. Birge et al.
CELL DEATH AND DIFFERENTIATION (2016)
An essential receptor for adeno-associated virus infection
S. Pillay et al.
NATURE (2016)
Towards programming immune tolerance through geometric manipulation of phosphatidylserine
Reid A. Roberts et al.
BIOMATERIALS (2015)
Use of Autoantigen-Loaded Phosphatidylserine-Liposomes to Arrest Autoimmunity in Type 1 Diabetes
Irma Pujol-Autonell et al.
PLOS ONE (2015)
Xk-Related Protein 8 and CED-8 Promote Phosphatidylserine Exposure in Apoptotic Cells
Jun Suzuki et al.
SCIENCE (2013)
Humoral immune response to AAV
Roberto Calcedo et al.
FRONTIERS IN IMMUNOLOGY (2013)
Immune Tolerance Induction Therapy for Patients With Hemophilia A and FVIII Inhibitors Particularly Using Low-Dose Regimens
Pei-Chin Lin et al.
PEDIATRIC BLOOD & CANCER (2011)
Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors
Sylvie Boutin et al.
HUMAN GENE THERAPY (2010)
Calcium-dependent phospholipid scrambling by TMEM16F
Jun Suzuki et al.
NATURE (2010)
Utility of PEGylated recombinant adeno-associated viruses for gene transfer
HT Le et al.
JOURNAL OF CONTROLLED RELEASE (2005)
PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization
GK Lee et al.
BIOTECHNOLOGY AND BIOENGINEERING (2005)
分享论文
